XT
KZR

XTX Topco’s Kezar Life Sciences KZR Stock Holding History

XTX Topco’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,495
Closed -$145K – 4457
2026
Q1 		$145K Buy
+19,495
New +$127K ﹤0.01% 2972
2024
Q4 		– Sell
-5,215
Closed -$40.3K – 2633
2024
Q3 		$40.3K Buy
5,215
+3,751
+256% +$22.6K ﹤0.01% 1725
2024
Q2 		$8.79K Sell
1,464
-208
-12% -$1.58K ﹤0.01% 1702
2024
Q1 		$15.1K Sell
1,672
-2,730
-62% -$24.9K ﹤0.01% 1636
2023
Q4 		$41.7K Sell
4,402
-2,766
-39% -$24.3K 0.01% 1261
2023
Q3 		$85.3K Sell
7,168
-2,296
-24% -$40.7K 0.01% 1204
2023
Q2 		$232K Buy
+9,464
New +$246K 0.04% 909
2022
Q4 		– Sell
-1,830
Closed -$158K – 1326
2022
Q3 		$158K Buy
+1,830
New +$178K 0.04% 854

XTX Topco's KZR Position: Q2 2026 in Review

XTX Topco sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 19,495 shares — an estimated $145K sold.

XTX Topco first reported a position in KZR in Q3 2022 and held it in 8 quarters. The position peaked at $232K in Q2 2023. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

  • XTX Topco reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 19,495 Kezar Life Sciences shares in Q2 2026, an estimated $145K.
  • XTX Topco first reported a position in Kezar Life Sciences in Q3 2022 and held it in 8 quarters.
  • XTX Topco's Kezar Life Sciences position peaked at $232K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.